Market Research Reports and Industry Reports

Transplant Diagnostics Market by Technology (SSO-PCR, SSP-PCR, NGS, Sangers Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The global transplant diagnostics market is projected to reach USD 753.9 million by 2021 from USD 535.0 million in 2016, growing at a CAGR of 7.1%, during 2016 to 2021. Market growth can be attributed to factors such as rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements; and increased funding, research grants, and public-private investments. However, high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedures restrain the growth of the transplant diagnostics market. Furthermore, the technological shift from serological assays to gene-based HLA profiling and improving healthcare infrastructure across developing countries provide various opportunities in the transplant diagnostics market. The significant gap between the number of organs donated and the number of organs required annually is however a major challenge limiting the growth of the global transplant diagnostics market to a certain extent.
 
 In this report, the global transplant diagnostics market is segmented on the basis of technology into molecular assay technology [including PCR-based (sequence-specific oligonucleotide and sequence-specific primer-PCR) and sequencing-based (next-generation sequencing and Sanger sequencing)] and non-molecular assay technology (includes serological and mixed lymphocyte culture assay); products and services (reagents and consumables, instruments, and software & services); applications (diagnostic and research); and end users (hospitals & transplant centers, commercial service providers, and research laboratories & academic institutes).
 
 Geographically, North America and Europe are expected to be the mature markets for transplant diagnostics products in 2016. The North American transplant diagnostics market is expected to hold the largest share of global transplant diagnostics market in 2016; it is projected to grow at the highest CAGR during the forecast period owing to easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS), increasing prevalence of target diseases (such as cancer, heart failure, and renal diseases) in the U.S. and Canada, and continuous technological advancements in the field of transplant diagnostics.
 
 As of 2015, the key players in the transplant diagnostics market included Thermo Fischer Scientific, Inc. (U.S.), Immucor, Inc. (U.S), Olerup SSp AB (Sweden), QIAGEN, Inc. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Affymetrix, Inc. (U.S.), Illumina Inc. (U.S.), Luminex Corporation, (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Abbott Laboratories, Inc. (U.S.), among others.
 
 Reasons to Buy the Report:
 
 From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the transplant diagnostics market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
 
 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner a higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
 
 The report provides insights on the following pointers:
 
 • Market Penetration: Comprehensive information on the transplant diagnostic products offered by the top 10 players in the global market. The report analyzes the transplant diagnostics market by technology, products and services, end user, and application across key geographic regions
 
 • Product Development/Innovation: Detailed insights on the upcoming transplant diagnostics products, research and development activities, and new product launches in the market
 
 • Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the markets for various transplant diagnostic products across key geographic regions
 
 • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global transplant diagnostics market
 
 • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global transplant diagnostics market

 

 1 INTRODUCTION 16
 1.1 OBJECTIVES OF THE STUDY 16
 1.2 MARKET DEFINITION 16
 1.3 MARKET SCOPE 17
 1.3.1 MARKETS COVERED 17
 1.3.2 GEOGRAPHIC SCOPE 17
 1.3.3 YEARS CONSIDERED FOR THE STUDY 18
 1.4 CURRENCY 18
 1.5 LIMITATIONS 18
 1.6 STAKEHOLDERS 19
 2 RESEARCH METHODOLOGY 20
 2.1 RESEARCH DATA 20
 2.1.1 SECONDARY DATA 21
 2.1.1.1 Key data from secondary sources 21
 2.1.2 PRIMARY DATA 22
 2.1.2.1 Key data from primary sources 22
 2.1.2.2 Breakdown of Primaries 23
 2.2 OPPORTUNITY INDICATORS 23
 2.2.1 INTRODUCTION 23
 2.2.2 DEMAND-SIDE ANALYSIS 24
 2.2.2.1 Healthcare expenditure patterns 24
 2.2.2.2 Rapid growth in geriatric population 27
 2.2.2.3 Rising incidence and prevalence of cancer 29
 2.2.2.4 Growing burden of cardiovascular diseases (CVDs) 31
 2.2.2.5 Increasing number of organ donations and transplantations 33
 2.2.3 SUPPLY-SIDE ANALYSIS 34
 2.2.3.1 Number of new product launches: transplant diagnostics Vs. competitive technologies 34
 2.2.3.2 Parent market analysis: Immunoassay market 35
 2.3 MARKET SIZE ESTIMATION 36
 2.3.1 BOTTOM-UP APPROACH 36
 2.3.2 TOP-DOWN APPROACH 38
 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 39
 2.5 RESEARCH ASSUMPTIONS 40
 2.5.1 ASSUMPTIONS 40
  
 3 EXECUTIVE SUMMARY 41
 3.1 INTRODUCTION 41
 3.2 CURRENT SCENARIO 41
 3.3 FUTURE OUTLOOK 42
 3.4 CONCLUSION 47
 4 PREMIUM INSIGHTS 48
 4.1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET OVERVIEW 48
 4.2 GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY REGION (2016) 49
 4.3 GLOBAL TRANSPLANT DIAGNOSTICS PRODUCT AND SERVICES MARKET, BY REGION (2016-2021) 50
 4.4 GLOBAL TRANSPLANT DIAGNOSTICS APPLICATIONS MARKET, BY REGION (2016-2021) 51
 4.5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER (2016–2021) 51
 4.6 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY (2016–2021) 52
 5 MARKET OVERVIEW 53
 5.1 INTRODUCTION 54
 5.2 MARKET SEGMENTATION 54
 5.3 MARKET DYNAMICS 55
 5.3.1 KEY MARKET DRIVERS 56
 5.3.1.1 Growing number of solid organ, soft-tissue, and stem cell transplantation procedures 56
 5.3.1.2 Technological advancements in the field of HLA typing 57
 5.3.1.3 Increased funding, research grants, and public-private investments 58
 5.3.2 KEY MARKET RESTRAINTS 59
 5.3.2.1 High cost of NGS and PCR-based devices 59
 5.3.2.2 Limited medical reimbursements for organ donation and transplantation procedures 60
 5.3.3 KEY MARKET OPPORTUNITIES 60
 5.3.3.1 Technological shift from serological assays to gene-based HLA profiling 60
 5.3.3.2 Improving healthcare infrastructure across developing countries 61
 5.3.4 KEY MARKET CHALLENGES 62
 5.3.4.1 Significant gap between number of organs donated and organs required annually 62
 6 INDUSTRY INSIGHTS 63
 6.1 INTRODUCTION 63
 6.2 VALUE CHAIN ANALYSIS 63
 6.3 INDUSTRY TRENDS 65
 6.3.1 INTEGRATION OF ADVANCED TECHNOLOGIES WITH MOLECULAR ASSAY PROCEDURE 65
  
 6.4 PORTER’S FIVE FORCES ANALYSIS 66
 6.4.1 THREAT OF NEW ENTRANTS 67
 6.4.2 THREAT OF SUBSTITUTES 67
 6.4.3 BARGAINING POWER OF SUPPLIERS 67
 6.4.4 BARGAINING POWER OF BUYERS 68
 6.4.5 INTENSITY OF COMPETITIVE RIVALRY 68
 7 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 69
 7.1 INTRODUCTION 70
 7.2 MOLECULAR ASSAYS 71
 7.2.1 PCR-BASED MOLECULAR ASSAYS 72
 7.2.1.1 SEQUENCE-SPECIFIC PRIMER (SSP)-PCR 73
 7.2.1.2 SEQUENCE-SPECIFIC OLIGONUCLEOTIDE (SSO)-PCR 74
 7.2.2 SEQUENCING-BASED MOLECULAR ASSAYS 75
 7.2.2.1 SANGER SEQUENCING 77
 7.2.2.2 NEXT-GENERATION SEQUENCING (NGS) 78
 7.3 NON-MOLECULAR ASSAYS 79
 7.3.1 SEROLOGICAL ASSAYS 80
 7.3.2 MIXED LYMPHOCYTE CULTURE (MLC) ASSAYS 81
 8 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES 82
 8.1 INTRODUCTION 83
 8.2 REAGENTS AND CONSUMABLES 84
 8.3 INSTRUMENTS 85
 8.4 SOFTWARE AND SERVICES 86
 9 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 87
 9.1 INTRODUCTION 88
 9.2 DIAGNOSTIC APPLICATIONS 89
 9.3 RESEARCH APPLICATIONS 90
 10 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 92
 10.1 INTRODUCTION 93
 10.2 HOSPITALS AND TRANSPLANT CENTERS 95
 10.3 COMMERCIAL SERVICE PROVIDERS 96
 10.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 97
  
 11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION 98
 11.1 INTRODUCTION 99
 11.2 NORTH AMERICA 100
 11.2.1 U.S. 102
 11.2.2 CANADA 104
 11.3 EUROPE 106
 11.3.1 GERMANY 108
 11.3.2 U.K. 109
 11.3.3 FRANCE 111
 11.3.4 REST OF EUROPE (ROE) 113
 11.4 ASIA-PACIFIC 115
 11.4.1 JAPAN 117
 11.4.2 CHINA 118
 11.4.3 INDIA 120
 11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 122
 11.5 REST OF THE WORLD (ROW) 124
 12 COMPETITIVE LANDSCAPE 128
 12.1 OVERVIEW 128
 12.2 MARKET SHARE ANALYSIS 129
 12.3 COMPETITIVE SCENARIO 131
 12.4 RECENT DEVELOPMENTS 132
 12.4.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 132
 12.4.2 NEW PRODUCT LAUNCHES, APPROVALS, AND PRODUCT ENHANCEMENTS 133
 12.4.3 STRATEGIC ACQUISITIONS 134
 12.4.4 GEOGRAPHIC EXPANSIONS 135
 13 COMPANY PROFILES 136
 (Business Overview, Products & Services, Developments, MnM View)*
 
 13.1 INTRODUCTION 136
 13.1.1 GEOGRAPHIC BENCHMARKING 136
 13.1.2 STRATEGIC BENCHMARKING 137
 13.1.2.1 Capacity building and capability enhancement 137
 13.2 THERMO FISHER SCIENTIFIC, INC. 138
 13.3 IMMUCOR, INC. 143
 13.4 OLERUP SSP AB 147
 13.5 QIAGEN N.V. 149
 13.6 BIO-RAD LABORATORIES, INC. 154
 13.7 ILLUMINA, INC. 159
 13.8 AFFYMETRIX, INC. 163
 13.9 F. HOFFMANN-LA-ROCHE LIMITED 166
 13.10 LUMINEX CORPORATION 168
 13.11 ABBOTT LABORATORIES, INC. 171
 
 *Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.
 14 APPENDIX 174
 14.1 INSIGHTS OF INDUSTRY EXPERTS 174
 14.2 DISCUSSION GUIDE 175
 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 179
 14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 181
 14.5 AVAILABLE CUSTOMIZATIONS 182
 14.6 RELATED REPORTS 183

 


List Of Tables

 TABLE 1 TOTAL COST OF TRANSPLANT PROCEDURES IN THE U.S.: BY ORGAN TRANSPLANTATION STAGES (INCLUDING TRANSPLANT DIAGNOSIS AND MONITORING) 59
 TABLE 2 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 70
 TABLE 3 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR MOLECULAR ASSAYS,
 BY TYPE, 2014-2021 (USD MILLION) 71
 TABLE 4 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR MOLECULAR ASSAYS, BY REGION, 2014-2021 (USD MILLION) 72
 TABLE 5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2014-2021 (USD MILLION) 72
 TABLE 6 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR PCR-BASED MOLECULAR ASSAYS, BY REGION, 2014-2021 (USD MILLION) 73
 TABLE 7 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SSP-PCR-BASED MOLECULAR ASSAYS, BY REGION, 2014-2021 (USD MILLION) 74
 TABLE 8 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SSO-PCR-BASED MOLECULAR ASSAYS, BY REGION, 2014-2021 (USD MILLION) 75
 TABLE 9 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2014-2021 (USD MILLION) 76
 TABLE 10 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2014-2021 (USD MILLION) 76
 TABLE 11 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SANGER SEQUENCING,
 BY REGION, 2014-2021 (USD MILLION) 77
 TABLE 12 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR NGS, BY REGION,
 2014-2021 (USD MILLION) 78
 TABLE 13 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR NON-MOLECULAR ASSAYS,
 BY TYPE, 2014-2021 (USD MILLION) 79
 TABLE 14 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR NON-MOLECULAR ASSAYS,
 BY REGION, 2014-2021 (USD MILLION) 80
 TABLE 15 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SEROLOGICAL ASSAYS, BY REGION, 2014-2021 (USD MILLION) 80
 TABLE 16 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR MLC ASSAYS, BY REGION,
 2014-2021 (USD MILLION) 81
 TABLE 17 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 83
 TABLE 18 TRANSPLANT DIAGNOSTIC REAGENTS AND CONSUMABLES MARKET SIZE,
 BY REGION, 2014-2021 (USD MILLION) 84
 TABLE 19 TRANSPLANT DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION,
 2014-2021 (USD MILLION) 85
 TABLE 20 TRANSPLANT DIAGNOSTIC SOFTWARE AND SERVICES MARKET SIZE,
 BY REGION, 2014-2021 (USD MILLION) 86
 TABLE 21 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 88
 TABLE 22 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS,
 BY REGION, 2014-2021 (USD MILLION) 89
 TABLE 23 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR RESEARCH APPLICATIONS,
 BY REGION, 2014-2021 (USD MILLION) 91
 TABLE 24 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014–2021 (USD MILLION) 93
 TABLE 25 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION, 2014–2021 (USD MILLION) 95
 TABLE 26 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2014–2021 (USD MILLION) 96
 TABLE 27 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014–2021 (USD MILLION) 97
 TABLE 28 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 99
 TABLE 29 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY,
 2014-2021 100
 TABLE 30 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 102
 TABLE 31 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES,
 2014-2021 (USD MILLION) 103
 TABLE 32 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 103
 TABLE 33 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 103
 TABLE 34 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 104
 TABLE 35 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 104
 TABLE 36 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 105
 TABLE 37 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 105
 TABLE 38 EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY,
 2014-2021 (USD MILLION) 106
 TABLE 39 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 108
 TABLE 40 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 108
 TABLE 41 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 109
 TABLE 42 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 109
 TABLE 43 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 110
 TABLE 44 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES,
 2014-2021 (USD MILLION) 110
 TABLE 45 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 110
 TABLE 46 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 111
 TABLE 47 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 111
 TABLE 48 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 112
 TABLE 49 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 112
 TABLE 50 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 112
 TABLE 51 ROE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 113
 TABLE 52 ROE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES,
 2014-2021 (USD MILLION) 113
 TABLE 53 ROE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 114
 TABLE 54 ROE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 114
 TABLE 55 ASIA-PACIFIC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY,
 2014-2021 (USD MILLION) 115
 TABLE 56 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 117
 TABLE 57 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 117
 TABLE 58 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 118
 TABLE 59 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 118
 TABLE 60 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 119
 TABLE 61 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 119
 TABLE 62 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 119
 TABLE 63 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 120
 TABLE 64 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 121
 TABLE 65 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 121
 TABLE 66 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 121
 TABLE 67 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 122
 TABLE 68 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 122
 TABLE 69 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 123
 TABLE 70 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 123
 TABLE 71 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 123
 TABLE 72 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2014-2021 (USD MILLION) 126
 TABLE 73 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION) 126
 TABLE 74 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION,
 2014-2021 (USD MILLION) 126
 TABLE 75 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER,
 2014-2021 (USD MILLION) 127
 TABLE 76 TOP AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2016 132
 TABLE 77 TOP NEW PRODUCT LAUNCHES, APPROVALS, AND PRODUCT ENHANCEMENTS, 2012–2016 133
 TABLE 78 TOP STRATEGIC ACQUISITIONS, 2012–2016 134
 TABLE 79 TOP GEOGRAPHICAL EXPANSIONS, 2012–2016 135


List Of Figures

 FIGURE 1 RESEARCH DESIGN 20
 FIGURE 2 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000–2013 24
 FIGURE 3 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS: 2000–2013 25
 FIGURE 4 HEALTHCARE SPENDING MATRIX: KEY MARKETS (2013) 26
 FIGURE 5 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011–2030) 27
 FIGURE 6 INCREASE IN THE PROPORTION OF THE ELDERLY IN THE OVERALL POPULATION, BY COUNTRY (2011–2030) 28
 FIGURE 7 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION
 (1980–2010 VS. 2010–2040) 28
 FIGURE 8 GLOBAL BURDEN OF CANCER, BY REGION (2005–2030) 29
 FIGURE 9 NUMBER OF NEW CANCER CASES, BY COUNTRY (2012–2020) 30
 FIGURE 10 INCREASING INCIDENCE OF VARIOUS CANCERS, 2008–2020 31
 FIGURE 11 GLOBAL BURDEN OF CARDIOVASCULAR DISEASES, BY REGION (2005–2030) 32
 FIGURE 12 NUMBER OF LIVING AND DECEASED ORGAN DONATIONS, BY COUNTRY
 (2010–2014) 33
 FIGURE 13 NUMBER OF NEW PRODUCT LAUNCHES: TRANSPLANT DIAGNOSTIC ASSAY VS. COMPETITIVE MODALITIES, 2012–2015 35
 FIGURE 14 MOLECULAR ASSAY-BASED TRANSPLANT DIAGNOSTIC TECHNOLOGY IS EXPECTED TO BE THE FASTEST-GROWING IMMUNOASSAY TECHNOLOGY BY 2021 36
 FIGURE 15 BOTTOM-UP APPROACH: TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET 37
 FIGURE 16 BOTTOM-UP APPROACH: TRANSPLANT DIAGNOSTIC REAGENTS AND CONSUMABLES MARKET 37
 FIGURE 17 TOP-DOWN APPROACH 38
 FIGURE 18 DATA TRIANGULATION 39
 FIGURE 19 ASSUMPTIONS OF THE RESEARCH STUDY 40
 FIGURE 20 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
 2016 VS. 2021 42
 FIGURE 21 GEOGRAPHIC ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2016 43
 FIGURE 22 GEOGRAPHIC ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 44
 FIGURE 23 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021 45
 FIGURE 24 TRANSPLANT DIAGNOSTICS MARKET SHARE, BY REGION, 2016 46
 FIGURE 25 GROWING NUMBER OF TRANSPLANTATION PROCEDURES TO DRIVE THE MARKET GROWTH FOR TRANSPLANT DIAGNOSTICS 48
 FIGURE 26 NORTH AMERICA IS EXPECTED TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, IN 2016 49
 FIGURE 27 REAGENTS AND CONSUMABLES TO DOMINATE THE TRANSPLANT DIAGNOSTICS PRODUCTS MARKET DURING THE FORECAST PERIOD 50
 FIGURE 28 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF TRANSPLANT DIAGNOSTICS APPLICATIONS MARKET IN 2016 51
 FIGURE 29 HOSPITALS AND TRANSPLANT CENTERS TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 51
 FIGURE 30 U.S. AND GERMANY ARE EXPECTED TO DOMINATE THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET TILL 2021 52
 FIGURE 31 TRANSPLANT DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
 FIGURE 32 NUMBER OF ORGAN TRANSPLANT PROCEDURES, 2010–2013 57
 FIGURE 33 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010–2013) 61
 FIGURE 34 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED TO THE OVERALL PRODUCT PRICING DURING R&D PHASE 64
 FIGURE 35 PORTER’S FIVE FORCES ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET (2015) 66
 FIGURE 36 GROWING ADOPTION OF PCR- AND NGS-BASED PRODUCTS IS PROPELLING REVENUE GROWTH FOR MOLECULAR ASSAYS MARKET 70
 FIGURE 37 NGS-BASED DEVICES ARE EXPECTED TO FORM THE FASTEST-GROWING MOLECULAR ASSAY TECHNOLOGY SEGMENT TILL 2021 71
 FIGURE 38 SEROLOGICAL ASSAY TECHNIQUE IS EXPECTED TO WITNESS POSITIVE MARKET GROWTH DURING 2016-2021 79
 FIGURE 39 REAGENTS AND CONSUMABLES SEGMENT TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD (2016–2021) 83
 FIGURE 40 DIAGNOSTIC APPLICATIONS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 88
 FIGURE 41 THE HOSPITALS & TRANSPLANT CENTERS END-USER SEGMENT IS EXPECTED TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET IN 2016 94
 FIGURE 42 U.S. AND GERMANY TO GROW AT THE HIGHEST RATES IN THE TRANSPLANT DIAGNOSTICS MARKET 99
 FIGURE 43 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT: 2016-2021 101
 FIGURE 44 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT: 2016-2021 107
 FIGURE 45 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT: 2016-2021 116
 FIGURE 46 ROW TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT: 2016-2021 125
 FIGURE 47 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS: KEY GROWTH STRATEGY ADOPTED BY A MAJORITY OF MARKET PLAYERS FROM 2012 TO 2016 128
 FIGURE 48 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SHARE, KEY PLAYER, 2015 129
 FIGURE 49 GROWING NUMBER OF AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS IS STIMULATING MARKET COMPETITION AMONG KEY PRODUCTS MANUFACTURERS 131
 FIGURE 50 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS* (2015) 136
 FIGURE 51 CAPACITY BUILDING AND CAPABILITY ENHANCEMENT: A KEY GROWTH STRATEGY ADOPTED BY MAJOR MARKET PLAYERS 137
 FIGURE 52 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 138
 FIGURE 53 IMMUCOR, INC.: COMPANY SNAPSHOT 143
 FIGURE 54 QIAGEN N.V.: COMPANY SNAPSHOT 149
 FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 154
 FIGURE 56 ILLUMINA, INC.: COMPANY SNAPSHOT 159
 FIGURE 57 AFFYMETRIX, INC.: COMPANY SNAPSHOT 163
 FIGURE 58 F. HOFFMANN-LA-ROCHE LTD: COMPANY SNAPSHOT 166
 FIGURE 59 LUMINEX CORPORATION: COMPANY SNAPSHOT 168
 FIGURE 60 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 171


Transfusion & Transplantation Technologies Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Transfusion & Transplantation Technologies Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

Musculoskeletal Transplant Foundation Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Musculoskeletal Transplant Foundation Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Glycorex Transplantation AB Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Glycorex Transplantation AB Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

Global Tissue Diagnostics Market Research Report 2016

Notes:Production, means the output of Tissue DiagnosticsRevenue, means the sales value of Tissue DiagnosticsThis report studies Tissue Diagnostics in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Europe Pap Smear/Papillomavirus (HPV) Diagnostics Market: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Complete report $2,850. DataPack (test volumes, sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance

USD 2850View Report

Europe Immunoprotein Diagnostics Market 2017-2921: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

This new 273-page report provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report

USD 6500View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4650
  • Multi User Licence    $ 5650
  • Corporate Licence    $ 7150
  • Enterprise Wide Licence    $ 9000
$ 4650

Reports Details

Published Date : May 2016
No. of Pages :184
Country :Global
Category :Healthcare
Publisher :MarketsandMarkets
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment